Accelovance   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Washington DC United States (2004)
Status: Acquired by Linical Co., Ltd. (2018)

Organization Overview

First Clinical Trial
2005
NCT00170469
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Accelovance | Accelovance LLC | Linical Accelovance | Linical Accelovance Group